171 related articles for article (PubMed ID: 8331683)
1. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.
Zacharski LR; Memoli VA; Ornstein DL; Rousseau SM; Kisiel W; Kudryk BJ
J Natl Cancer Inst; 1993 Aug; 85(15):1225-30. PubMed ID: 8331683
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Anticancer Res; 1990; 10(3):579-82. PubMed ID: 2114816
[TBL] [Abstract][Full Text] [Related]
4. Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium.
Young TN; Rodriguez GC; Moser TL; Bast RC; Pizzo SV; Stack MS
Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1285-96. PubMed ID: 8178854
[TBL] [Abstract][Full Text] [Related]
5. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Am J Clin Pathol; 1990 Apr; 93(4):516-21. PubMed ID: 1690950
[TBL] [Abstract][Full Text] [Related]
7. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Moritz TE; Rousseau SM; Stump DC
Cancer; 1991 Mar; 67(5):1377-83. PubMed ID: 1703919
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung.
Nakstad B; Lyberg T
APMIS; 1991 Nov; 99(11):981-8. PubMed ID: 1720319
[TBL] [Abstract][Full Text] [Related]
9. Localization of blood coagulation factors in situ in pancreatic carcinoma.
Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of components of fibrinolysis pathways in situ in neoplastic and nonneoplastic human breast tissue.
Costantini V; Zacharski LR; Memoli VA; Kudryk BJ; Rousseau SM; Stump DC
Cancer Res; 1991 Jan; 51(1):354-8. PubMed ID: 1846311
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
12. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
Ornstein DL; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Hunt J; Rousseau SM; Stump DC
Cancer; 1991 Sep; 68(5):1061-7. PubMed ID: 1913476
[TBL] [Abstract][Full Text] [Related]
13. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Cancer; 1990 Feb; 65(3):481-5. PubMed ID: 2153429
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
Camiolo SM; Greco WR
Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.
Hasday JD; Bachwich PR; Lynch JP; Sitrin RG
Exp Lung Res; 1988; 14(2):261-78. PubMed ID: 3371278
[TBL] [Abstract][Full Text] [Related]
16. Indirect activation of blood coagulation in colon cancer.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Thromb Haemost; 1989 Dec; 62(4):1062-6. PubMed ID: 2694422
[TBL] [Abstract][Full Text] [Related]
17. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
Zhang W; Ling D; Tan J; Zhang J; Li L
Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
[TBL] [Abstract][Full Text] [Related]
18. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Zimnoch L; Kudryk B; Kisiel W
Semin Thromb Hemost; 2003 Jun; 29(3):291-300. PubMed ID: 12888933
[TBL] [Abstract][Full Text] [Related]
20. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
